Lead sponsor
NYU Langone Health
7 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
7
Trials led
2
Ongoing
145
Total enrollment
7
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
2
Phase 4
4
Not applicable
1
Trials by status
Recruiting
2
Completed
3
Terminated
1
Withdrawn
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Detecting an Early Response to Donepezil With Measures of Visual AttentionAlzheimer's diseasePh 4Completed25
Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver TrainingAlzheimer's diseasePh 4Completed20
Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's DiseaseFamily history of Alzheimer’s disease requiredPh 4Completed17
A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 FlutemetamolStudy partner/caregiver requiredPh 1Terminated5